DIM inhibits colon cancer by activating AhR (aryl hydrocarbon receptor), as well as inhibiting breast cancer, ovarian cancer, uterine cancer, and lung adenocarcinoma by normalizing the sex hormone metabolism [80,81]. Here, AHR is linked to breast carcinoma.